Market Place
Sourcing Support
Microbot Medical Inc. Appoints Alon Tamir As VP Sales EMEA
01 May 2026 //
INDPHARMAPOST
Microbot Medical Names Exec to Lead Expansion in EMEA
30 Apr 2026 //
GLOBENEWSWIRE
Microbot Medical To Showcase LIBERTY Endovascular Robotic System
14 Apr 2026 //
GLOBENEWSWIRE
Microbot Medical To Attend Roth Conference
17 Mar 2026 //
GLOBENEWSWIRE
Microbot Medical To Debut At Oppenheimer Healthcare Medtech
10 Mar 2026 //
GLOBENEWSWIRE
Microbot Medical Aligns With Largest U.S. Medical Association
04 Mar 2026 //
PHARMIWEB
Microbot`s LIBERTY Robotic System Shines at Vascular Conference
12 Feb 2026 //
GLOBENEWSWIRE
Microbot Medical Presents LIBERTY at the Oncology Conference
05 Feb 2026 //
GLOBENEWSWIRE
Microbot Medical to Launch Liberty System at Oncology Meeting
16 Oct 2025 //
GLOBENEWSWIRE
Microbot Medical Completes $92.2M Preferred Investment Options
07 Oct 2025 //
GLOBENEWSWIRE
Microbot Medical Secures Initial Patent In Japan, Expanding
01 Oct 2025 //
GLOBENEWSWIRE
Microbot Medical Announces $92.2M Preferred Investment Exercise
15 Sep 2025 //
GLOBENEWSWIRE
Microbot Medical Gets US Patent for Expanded Market Applications
21 Aug 2025 //
PHARMAWEB
Microbot Medical® Appoints Christina Bailey as VP of Sales
22 Jul 2025 //
GLOBENEWSWIRE
Microbot Medical Leads Robotics Talk at Surgery Meeting
08 Jul 2025 //
GLOBENEWSWIRE
Microbot Medical® Added to the Russell Microcap® Index
30 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical strengthens global IP with new patent in China
17 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical Strengthens Commercial Capabilities for Q3 2025
09 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical Chosen for Russell Microcap® Index
05 Jun 2025 //
GLOBENEWSWIRE
Microbot Medical® Adds Experienced Healthcare Officers to Leader
23 Apr 2025 //
GLOBENEWSWIRE
Microbot Medical to Present Data at SIR Annual Meeting
01 Apr 2025 //
GLOBENEWSWIRE
Microbot Hires Sales Executive To Lead US Liberty® Expansion
04 Mar 2025 //
GLOBENEWSWIRE
Microbot Medical Closes $13 Million Registered Direct Offering
11 Feb 2025 //
GLOBENEWSWIRE
Microbot Medical Announces $13M Registered Offering under Nasdaq
10 Feb 2025 //
GLOBENEWSWIRE
Microbot Strengthens Team Ahead Of LIBERTY® Commercial Launch
21 Jan 2025 //
GLOBENEWSWIRE
Microbot Adds David J. Wilson To Board For Commercial Expansion
13 Jan 2025 //
GLOBENEWSWIRE
Microbot Medical Closes $8.6 Million Registered Direct Offering
10 Jan 2025 //
GLOBENEWSWIRE
Microbot Closes $8.6M Direct Offering Under Nasdaq Market Rules
08 Jan 2025 //
GLOBENEWSWIRE
Microbot Raises $11.8M Via Offering And ATM Facility
07 Jan 2025 //
GLOBENEWSWIRE
Microbot Closes $7M Offering Under Nasdaq Rules At-The-Market
06 Jan 2025 //
GLOBENEWSWIRE
Microbot Medical Achieves Milestones for LIBERTY® FDA Submission
30 Dec 2024 //
GLOBENEWSWIRE
Microbot Medical Completes Trial Prepares For Liberty Launch
15 Oct 2024 //
GLOBENEWSWIRE
Microbot Medical Accelerates Patient Enrollment In Clinical Trial
30 Sep 2024 //
GLOBENEWSWIRE
Microbot Medical Signs Collaboration For LIBERTY® Robotic System
22 Aug 2024 //
GLOBENEWSWIRE
Microbot Medical Adds Memorial Sloan Kettering To Pivotal Clinical Trial
18 Jul 2024 //
GLOBENEWSWIRE
Microbot Medical Ramps Up Enrollment In Pivotal Human Clinical Trial
09 Jul 2024 //
GLOBENEWSWIRE
Microbot gets IRB approval for trial for robotic surgical
05 Jul 2024 //
PHARMABIZ
Microbot Partners With Brigham And Women’s For Pivotal Human Clinical Trial
20 Jun 2024 //
GLOBENEWSWIRE
Microbot Medical: $2.35M Direct Offering Priced At Nasdaq Market
04 Jun 2024 //
GLOBENEWSWIRE
Microbot $2.35M At-The-Market Registered Direct Offering
03 Jun 2024 //
GLOBENEWSWIRE
Microbot Gets FDA Approval For Pivotal Human Clinical Trial
03 Jun 2024 //
GLOBENEWSWIRE
Microbot Medical: Positive Results from Corewell Health™ Collaboration Phase 1
29 Apr 2024 //
GLOBENEWSWIRE
Microbot Shares Status Post Geopolitical Events
15 Apr 2024 //
GLOBENEWSWIRE
Microbot Submits an IDE Application to Gain FDA Approval to Commence Trial
05 Feb 2024 //
GLOBENEWSWIRE
Microbot Medical Announces Settlement and Release Agreement
30 Jan 2024 //
GLOBENEWSWIRE
Microbot Medical Expands US Clinical Infrastructure
18 Jan 2024 //
GLOBENEWSWIRE
Microbot Announces Exercise of Outstanding Investment Options for $2.73 Million
29 Dec 2023 //
GLOBENEWSWIRE
Microbot Announced Positive Results of Its GLP Pivotal Pre-Clinical Study
28 Dec 2023 //
GLOBENEWSWIRE
Microbot Medical and Corewell Health Forge Collaboration
14 Dec 2023 //
GLOBENEWSWIRE
Microbot Medical Announces the Successful Completion of GLP Pre-Clinical Study
07 Dec 2023 //
GLOBENEWSWIRE
Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as CMO
21 Nov 2023 //
GLOBENEWSWIRE
Microbot Medical Completed Integral Part of the Verification Process
13 Nov 2023 //
GLOBENEWSWIRE
Microbot Granted Registered Trademark from The U.S. Patent and Trademark Office
08 Nov 2023 //
GLOBENEWSWIRE
Microbot Reveals Short Term Follow Up Outcomes from its Pre-Clinical Study
31 Oct 2023 //
GLOBENEWSWIRE
Microbot Received Confirmation for Commencement of CE Mark Approval Process
24 Oct 2023 //
GLOBENEWSWIRE
Microbot Medical Announces Grant of Summary Judgment in its Favor
19 Oct 2023 //
GLOBENEWSWIRE
Microbot Medical Announces Outcomes from Study with the LIBERTY
17 Oct 2023 //
GLOBENEWSWIRE
Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial
27 Sep 2023 //
GLOBENEWSWIRE
Microbot Medical Gains Global Recognition
08 Sep 2023 //
GLOBENEWSWIRE
Microbot Medical Boosts Manufacturing Capabilities for Robotic Surgical System
15 Aug 2023 //
GLOBENEWSWIRE
